← Back to Search

Gait Retraining for Knee Osteoarthritis

N/A
Waitlist Available
Led By Michael A Hunt, PT, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
report knee pain greater than or equal to 3/10 on a numerical pain rating scale (0-10) during most days of the previous month
TFOA of Grade 2 (mild) or 3 (moderate) on the Kellgren and Lawrence scale
Must not have
non-English speaking
cardiovascular or cardiopulmonary disease preventing from safely performing moderate intensity running
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of a 4-week running gait retraining program on symptoms and running biomechanics in runners with Tibiofemoral osteoarthritis (TFOA).

Who is the study for?
This trial is for adult runners who have mild to moderate knee osteoarthritis, run at least 10 km weekly for over six months, can comfortably run on a treadmill for 30 minutes, and experience knee pain most days. It's not suitable for non-English speakers, those with recent serious knee injuries or certain medications, heart conditions that make running unsafe, or other leg issues affecting running.
What is being tested?
The study tests a 4-week program designed to change how people with knee osteoarthritis run (gait retraining). The goal is to see if these changes can reduce their symptoms like pain and improve their ability to function without putting too much stress on the knees.
What are the potential side effects?
Since this isn't a drug trial but an exercise-based intervention focusing on changing running style, side effects may include muscle soreness or fatigue due to new gait patterns. However, significant adverse effects are unlikely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have experienced knee pain of at least 3 out of 10 nearly every day last month.
Select...
My arthritis is mild to moderate according to the Kellgren and Lawrence scale.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I have heart or lung conditions that prevent me from safely doing moderate running.
Select...
I have a condition in my lower limb that affects my ability to run, not including TFOA.
Select...
I have had a serious knee injury in the past.
Select...
I have a neurological or inflammatory arthritis condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Knee
Peak knee adduction moment impulse change
Secondary study objectives
Numerical pain rating scale for pain during running change
Peak knee flexion moment impulse change
Step rate change
Other study objectives
Compliance with gait retraining change
Numeric pain rating scale for usual pain change
Numeric pain rating scale for worst pain change

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gait retrainingExperimental Treatment1 Intervention
Runners will be taught how to modify their running gait through multiple laboratory sessions and in-field training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gait retraining
2011
Completed Phase 2
~150

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,485,479 Total Patients Enrolled
26 Trials studying Osteoarthritis
1,960 Patients Enrolled for Osteoarthritis
Michael A Hunt, PT, PhDPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
199 Total Patients Enrolled
3 Trials studying Osteoarthritis
199 Patients Enrolled for Osteoarthritis

Media Library

Gait retraining Clinical Trial Eligibility Overview. Trial Name: NCT03314428 — N/A
Osteoarthritis Research Study Groups: Gait retraining
Osteoarthritis Clinical Trial 2023: Gait retraining Highlights & Side Effects. Trial Name: NCT03314428 — N/A
Gait retraining 2023 Treatment Timeline for Medical Study. Trial Name: NCT03314428 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03314428 — N/A
~7 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top